Bixiye
P5-24 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans managed by Blue Cross and Blue Shield of Alabama
Taariikhda uu dhaqangalayo Barnaamijka: Jan 02, 2024
Natiijooyinka Raadinta
Soo bandhiga 1241 - 1250 ee natiijooyinka 3686
Bixiye
2024 January Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: Jan 02, 2024
Bixiye
Oral Inhalers - Commercial
Step Therapy, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2025
Bixiye
Topical Corticosteroids - Medicaid
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2025
Bixiye
Vowst™ (fecal microbiota spores, live-brpk) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2024
Bixiye
Vowst™ (fecal microbiota spores, live-brpk) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2024
Bixiye
Winlevi® (clascoterone) - Commercial
Oggolaanshaha Hore
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2025
Bixiye
QP4-24 Blue Cross to End Collaboration with VillageHealth
Taariikhda uu dhaqangalayo Barnaamijka: Jan 10, 2024
Bixiye
P1-24 eviCore Healthcare Specialty Utilization Management (UM) Program: Medical Oncology Drug Prior Authorization Updates
Taariikhda uu dhaqangalayo Barnaamijka: Jan 02, 2024
Bixiye
P2-24 New Practitioner Credentialing Requirements Beginning in 2024
Taariikhda uu dhaqangalayo Barnaamijka: Jan 02, 2024